Shortened Obinutuzumab Infusion Is Safe and Reduces Chair Time in Frontline Treatment of Chronic Lymphocytic Leukemia: A Real‐World Study
- DOI
- 10.1002/cam4.72409
- Published
- 2026-11
- Container
- Cancer Medicine
- Publisher
- Wiley
- Open access
- unknown
Credibility signals
uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- supportingDOI registered: A matching record was returned by Crossref.
- supportingDOI resolves: A matching record was returned by Crossref.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredOpen access status: Not checked or no result supplied; no credibility inference made.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- supportingMetadata completeness: All 6 scored descriptive metadata groups are present.
Cite this work
BibTeX
@article{allodium:10.1002/cam4.72409,
title = {Shortened Obinutuzumab Infusion Is Safe and Reduces Chair Time in Frontline Treatment of Chronic Lymphocytic Leukemia: A Real‐World Study},
author = {Dominika Écsiová and Eva Vejražková and Pavel Vodárek and Petra Rozsívalová and Lukáš Smolej and Pavel Žák and Martin Šimkovič},
year = {2026},
journal = {Cancer Medicine},
doi = {10.1002/cam4.72409},
url = {https://doi.org/10.1002/cam4.72409}
}RIS
TY - JOUR TI - Shortened Obinutuzumab Infusion Is Safe and Reduces Chair Time in Frontline Treatment of Chronic Lymphocytic Leukemia: A Real‐World Study AU - Dominika Écsiová AU - Eva Vejražková AU - Pavel Vodárek AU - Petra Rozsívalová AU - Lukáš Smolej AU - Pavel Žák AU - Martin Šimkovič PY - 2026 JO - Cancer Medicine DO - 10.1002/cam4.72409 UR - https://doi.org/10.1002/cam4.72409 ER -
APA
Écsiová, D., Vejražková, E., Vodárek, P., Rozsívalová, P., Smolej, L., Žák, P., & Šimkovič, M. (2026). Shortened Obinutuzumab Infusion Is Safe and Reduces Chair Time in Frontline Treatment of Chronic Lymphocytic Leukemia: A Real‐World Study. Cancer Medicine. https://doi.org/10.1002/cam4.72409
Source records
- crossref · retrieved 2026-11-05T00:14:01.353Z